Supplementary Figure Legends from A Phase Ib/II Study of Ramucirumab in Combination with Emibetuzumab in Patients with Advanced Cancer
Year: 2023
Type: supplementary-materials
Abstract: Supplementary figures titles and legends are placed in this document
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361887564
